HUT77978A - Immunoterápiás alkalmazású imidek/amidok, ezek alkalmazása a TNFalfa koncentrációjának csökkentésében - Google Patents

Immunoterápiás alkalmazású imidek/amidok, ezek alkalmazása a TNFalfa koncentrációjának csökkentésében

Info

Publication number
HUT77978A
HUT77978A HU9701842A HU9701842A HUT77978A HU T77978 A HUT77978 A HU T77978A HU 9701842 A HU9701842 A HU 9701842A HU 9701842 A HU9701842 A HU 9701842A HU T77978 A HUT77978 A HU T77978A
Authority
HU
Hungary
Prior art keywords
tnfalfa
amides
reducing levels
immunotherapeutic
imides
Prior art date
Application number
HU9701842A
Other languages
English (en)
Other versions
HU226558B1 (en
Inventor
George W. Muller
Mary Shire
David I. Stirling
Original Assignee
Celgene Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Celgene Corporation filed Critical Celgene Corporation
Publication of HUT77978A publication Critical patent/HUT77978A/hu
Publication of HU226558B1 publication Critical patent/HU226558B1/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/46—Iso-indoles; Hydrogenated iso-indoles with an oxygen atom in position 1
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Indole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
HU9701842A 1994-12-30 1995-11-20 Immunotherapeutic imides/amides and their use for reducing levels of tnfalpha HU226558B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36666794A 1994-12-30 1994-12-30
PCT/US1995/015119 WO1996020705A1 (en) 1994-12-30 1995-11-20 IMMUNOTHERAPEUTIC IMIDES/AMIDES AND THEIR USE FOR REDUCING LEVELS OF TNF$g(a)

Publications (2)

Publication Number Publication Date
HUT77978A true HUT77978A (hu) 1999-01-28
HU226558B1 HU226558B1 (en) 2009-03-30

Family

ID=23443993

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9701842A HU226558B1 (en) 1994-12-30 1995-11-20 Immunotherapeutic imides/amides and their use for reducing levels of tnfalpha

Country Status (18)

Country Link
EP (1) EP0797437B1 (hu)
JP (1) JPH10511678A (hu)
AT (1) ATE200621T1 (hu)
AU (1) AU696817B2 (hu)
CA (1) CA2208672C (hu)
CZ (1) CZ290372B6 (hu)
DE (1) DE69520750T2 (hu)
DK (1) DK0797437T3 (hu)
ES (1) ES2155537T3 (hu)
FI (1) FI972708A (hu)
GR (1) GR3036131T3 (hu)
HU (1) HU226558B1 (hu)
NZ (1) NZ296925A (hu)
PL (1) PL185101B1 (hu)
PT (1) PT797437E (hu)
RU (1) RU2164514C2 (hu)
SK (1) SK86997A3 (hu)
WO (1) WO1996020705A1 (hu)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
EP0818439B1 (en) * 1996-07-02 1999-10-13 Nisshin Flour Milling Co., Ltd. Imide derivatives
CA2262900A1 (en) * 1996-08-05 1998-02-12 Molecumetics Ltd. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
EP1661566A3 (en) * 1996-08-05 2008-04-16 Myriad Genetics, Inc. Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors
US7091353B2 (en) 2000-12-27 2006-08-15 Celgene Corporation Isoindole-imide compounds, compositions, and uses thereof
WO2002068414A2 (en) 2001-02-27 2002-09-06 The Governement Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Analogs of thalidomide as potential angiogenesis inhibitors
US7498171B2 (en) 2002-04-12 2009-03-03 Anthrogenesis Corporation Modulation of stem and progenitor cell differentiation, assays, and uses thereof
US8952895B2 (en) 2011-06-03 2015-02-10 Apple Inc. Motion-based device operations
BRPI0414497A (pt) 2003-09-17 2006-11-14 Us Gov Health & Human Serv análogos de talidomida
US8927725B2 (en) 2011-12-02 2015-01-06 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Thio compounds

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU1531492A (en) * 1991-02-14 1992-09-15 Rockefeller University, The Method for controlling abnormal concentration tnf alpha in human tissues
US5463063A (en) * 1993-07-02 1995-10-31 Celgene Corporation Ring closure of N-phthaloylglutamines

Also Published As

Publication number Publication date
DK0797437T3 (da) 2001-06-05
CA2208672C (en) 2008-02-12
EP0797437A1 (en) 1997-10-01
AU696817B2 (en) 1998-09-17
PL321071A1 (en) 1997-11-24
WO1996020705A1 (en) 1996-07-11
DE69520750T2 (de) 2001-09-13
PL185101B1 (pl) 2003-02-28
EP0797437B1 (en) 2001-04-18
GR3036131T3 (en) 2001-09-28
HU226558B1 (en) 2009-03-30
AU4166796A (en) 1996-07-24
FI972708A (fi) 1997-08-29
CZ290372B6 (cs) 2002-07-17
CZ203597A3 (en) 1997-11-12
PT797437E (pt) 2001-07-31
SK86997A3 (en) 1998-01-14
DE69520750D1 (de) 2001-05-23
CA2208672A1 (en) 1996-07-11
RU2164514C2 (ru) 2001-03-27
ES2155537T3 (es) 2001-05-16
ATE200621T1 (de) 2001-05-15
JPH10511678A (ja) 1998-11-10
FI972708A0 (fi) 1997-06-23
NZ296925A (en) 1998-06-26

Similar Documents

Publication Publication Date Title
PL321072A1 (en) Novel immunotherapeutic aryl amides
PL321065A1 (en) Substituted imides as tnf inhibitors
DE69629716D1 (en) Succinimid und maleimid cytokin-inhibitoren
PL329107A1 (en) Inhibitors of alpha tumor necrosis factor
WO1998024763A3 (en) Immunotherapeutic imides/amides as pde iv and tnf inhibitors
HUT77978A (hu) Immunoterápiás alkalmazású imidek/amidok, ezek alkalmazása a TNFalfa koncentrációjának csökkentésében
AP9801354A0 (en) New use of N-(phosphonomethy ) glycine and derivatives therefor
NO924835D0 (no) Fremgangsmaate ved fremstilling av dobbelt-inhibitorer forno-syntetase og cyklooksygenase
CY2209B1 (en) Preparation containing a combination of 5-methylisoxazole-4-carboxylic acid-(4-trifluoromethyl) -an il ide and n- (4-trifluoromethylphenyl) 2-cyano-3-hydro xycrotonic acid amide
AU2093797A (en) Wood preservative for afterprotection
ZA865740B (en) N-substituted fused heterocyclic carboxamide derivatives as dual cyclooxygenase and lipoxygenase inhibitors
NO852793L (no) (pyrrol-1-yl)-fenyldihydropyridazinoner og fremgangsmaate ved fremstilling derav.
GB2295288B (en) Wideband constant impedance amplifiers
GR3019956T3 (en) Fungicidal mixtures.
NO893692D0 (no) Fremgangsmaate for fremstilling av s-(-) og r-(+)-n-(quinuclidinyl-3)-amider.
GB9022360D0 (en) Unitzed ball and socket head and pistol grip
IT1256019B (it) Benzofurano-imidazoli per uso come inibitori di aromatasie 17,20-liasi nella profilassi e trattamento del cancro della mammella e nell'iperplasia prostatica benigna
GR1002512B (el) Ψαροντουφεκο.
TW343129B (en) Indole derivative and rooting inducing agent containing the same as effective component

Legal Events

Date Code Title Description
MM4A Lapse of definitive patent protection due to non-payment of fees